Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
about
Biomarkers in heart failure with preserved ejection fractionObesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failureHeart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodelingRenal impairment and heart failure with preserved ejection fraction early post-myocardial infarctionDiagnostic value of patterns of symptoms and signs of heart failure: application of latent class analysis with concomitant variables in a cross-sectional study.Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyN-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.Clinical characteristics of emergency department heart failure patients initially diagnosed as non-heart failure.Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide.Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fractionRisk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: the Worcester Heart Failure Study.Assessing strategies for heart failure with preserved ejection fraction at the outpatient clinic.B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.Improving prognosis estimation in patients with heart failure and the cardiorenal syndromeDiagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsThe diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.Cardiac biomarkers in the intensive care unitCorrelation of natriuretic peptides and inferior vena cava size in patients with congestive heart failureAll patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fractionB-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.A comparison of criterion standard methods to diagnose acute heart failure.Role of angiotensin II in the evolution of diastolic heart failure.N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shockProspective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study.Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis.B-type natriuretic peptide in the diagnosis of heart failure in the emergency department.Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart diseaseB-type natriuretic peptide: a critical review.The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic reviewFocused cardiopulmonary ultrasound for assessment of dyspnea in a resource-limited setting.Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%.Dynamics of brain natriuretic peptide in critically ill patients with severe sepsis and septic shockPre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study.
P2860
Q26768192-FEB247BD-E0C6-41E1-A710-215BB2818582Q27027081-15540B88-26CE-4AF5-A50F-27DF6C4B37BCQ28482901-C9A653F8-32A6-414F-9025-BFB0705A4FCEQ30434062-A4E45022-6ECD-4184-AB4A-386D71417ECCQ30459347-8E0F3C2B-17B9-4151-BFCF-DB9F003A7A7FQ30461204-C3F0E33B-6F52-47CB-90E6-2FD5E5FEF71BQ30483582-AB89930C-D561-49C7-B025-BC39BFF0A944Q30908647-B247C0E5-238D-406A-87D4-B985BFD26A0DQ33222138-D5D57EA4-2F3F-4E05-B828-962C543B60C8Q33227738-8FED2B22-FE65-46CD-BA59-6EC5637C7BC3Q33263604-36C3624D-4D07-474E-BD6A-834AFA842CA9Q33774275-F1B0A888-2968-4BDA-A996-A38EE64E5503Q33917736-BE54D35B-E205-4ACD-8EA2-4B71D505AFC2Q33943433-E542DF0E-4C61-4B29-8548-C98E2B252226Q34319923-0F62D15C-2734-41C7-ADEF-162762631DBFQ35000296-0E02BE5F-450B-44A3-ADB4-4C1364CB7963Q35020305-62E30830-0551-4312-BAB0-90BD97AFDDCAQ35139959-7F3FB2DC-607B-494B-B31A-1E1EE541B821Q35717608-69A0372D-C844-4930-AC58-A73A0DB02F49Q35805412-55A70897-0AE7-45D8-A6A8-A3DF4999B8DDQ35856435-9B9E25BC-304E-4A11-93CA-C1F3F76F9354Q35905579-80F5E083-8ED1-45A4-A284-D524EC080266Q35987037-196118C7-2971-44F8-B26A-5BDA6F14B808Q35987052-41C6F7C5-6F00-4C6F-BF06-F5A26B754E49Q36124913-A325CE11-EF77-461B-AED1-183AC7A69FA5Q36203267-294B44AE-3C66-4E0A-970A-27640F2659B1Q36245755-4F4C7BC0-8FB4-4B17-BB8E-D60098AE2DB8Q36281124-DD7558A9-79DB-4C91-9315-2052CA0FB5C7Q36332211-8877CCBF-0F2D-4A73-8995-B6C5D3CF8A1EQ36392546-D25F7728-636F-4788-95A1-BD50DE3F1F14Q36426776-CD9BD46C-3751-4C37-AFF2-AAF8388B0E79Q36437188-C8A8A9DC-4CA9-4E68-A3B3-F6B884F5D745Q36466739-7A9A296A-0E99-4809-8198-64363760F6D5Q36694171-A6C7503F-3AFB-42F3-B99E-C7A18219C14EQ36724549-D3F8EA3A-6617-4210-9EB5-F18ACB40D304Q36861935-B2025674-7456-4821-BEFA-D7BE872A41B1Q36968589-49752E6F-6E50-43E6-8CD8-BD8537FD1F55Q37082859-F9CE33FD-B913-4ECB-A4BA-EB69B39089D3Q37133738-0A034F27-02DB-485E-8555-CDC027AAC1C7Q37140904-77C23243-9E0F-43FA-8C3D-E419B669D93E
P2860
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@en
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@nl
type
label
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@en
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@nl
prefLabel
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@en
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@nl
P2093
P50
P1476
Bedside B-Type natriuretic pep ...... Properly Multinational Study.
@en
P2093
Alan H B Wu
Alan S Maisel
Alberto Perez
Arne Westheim
Breathing Not Properly Multinational Study Investigators
Cathrine Wold Knudsen
Howard C Herrmann
James McCord
Marie Claude Aumont
Padma Krishnaswamy
P304
P356
10.1016/S0735-1097(03)00405-4
P407
P577
2003-06-01T00:00:00Z